Comparative inhibition beta-lactamases by novel beta-lactam compounds
- PMID: 311616
- PMCID: PMC352628
- DOI: 10.1128/AAC.15.2.171
Comparative inhibition beta-lactamases by novel beta-lactam compounds
Abstract
The beta-lactamase-inhibiting activity of CP-45,899, 3,3-dimethyl-7-oxo-4-thia-1-azabicylo(3,2,0)heptane-2-carboxylic acid, 4,4-dioxide [2S-(2alpha,5alpha)], was investigated and compared with the beta-lactamase-inhibiting activity of clavulanic acid and dicloxacillin. CP-45,899 was an effective inhibitor of Staphylococcus aureus beta-lactamase and of those beta-lactamases of gram-negative bacteria which are primarily active against penicillins or equally active against penicillins and cephalosporins. The reaction of CP-45,899 with beta-lactamases was a concentration- and time-dependent event. CP-45,899 acted as a competitive inhibitor of plasmid-mediated S. aureus, Escherichia coli, and Shigella sonnei beta-lactamases and inducible Klebsiella beta-lactamase. CP-45,899 was a poor inhibitor of inducible or constitutive chromosomally mediated beta-lactamases of indole-positive Proteus, Citrobacter, and Enterobacter. CP-45,899 had lower kinetic constants for inhibition of hydrolysis than did clavulanic acid against many of the beta-lactamases which both inhibited.
Similar articles
-
Clavulanic acid, a novel inhibitor of beta-lactamases.Antimicrob Agents Chemother. 1978 Nov;14(5):650-5. doi: 10.1128/AAC.14.5.650. Antimicrob Agents Chemother. 1978. PMID: 310279 Free PMC article.
-
CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.Antimicrob Agents Chemother. 1978 Sep;14(3):414-9. doi: 10.1128/AAC.14.3.414. Antimicrob Agents Chemother. 1978. PMID: 309306 Free PMC article.
-
A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.J Antibiot (Tokyo). 1978 Dec;31(12):1238-44. doi: 10.7164/antibiotics.31.1238. J Antibiot (Tokyo). 1978. PMID: 310815
-
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8. Am J Med. 1985. PMID: 3907341 Review.
-
Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.Am J Health Syst Pharm. 1995 Mar 15;52(6 Suppl 2):S15-22. doi: 10.1093/ajhp/52.6_Suppl_2.S15. Am J Health Syst Pharm. 1995. PMID: 7606585 Review.
Cited by
-
Inactivation of beta-lactam antibiotics by Legionella pneumophila.Antimicrob Agents Chemother. 1979 Nov;16(5):561-4. doi: 10.1128/AAC.16.5.561. Antimicrob Agents Chemother. 1979. PMID: 316686 Free PMC article.
-
Penicillins--new insights into their mechanisms of activity and clinical use.Bull N Y Acad Med. 1982 Nov;58(8):681-95. Bull N Y Acad Med. 1982. PMID: 6762895 Free PMC article. Review. No abstract available.
-
A functional classification scheme for beta-lactamases and its correlation with molecular structure.Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33. doi: 10.1128/AAC.39.6.1211. Antimicrob Agents Chemother. 1995. PMID: 7574506 Free PMC article. Review. No abstract available.
-
Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime.Antimicrob Agents Chemother. 1981 Aug;20(2):262-4. doi: 10.1128/AAC.20.2.262. Antimicrob Agents Chemother. 1981. PMID: 6269489 Free PMC article.
-
Potent cephalosporinase inhibitors: 7 beta-[2-(1, 3-dithiolan-2-ylidene) acetamido] cephalosporins and related compounds.Antimicrob Agents Chemother. 1982 Apr;21(4):613-7. doi: 10.1128/AAC.21.4.613. Antimicrob Agents Chemother. 1982. PMID: 6979310 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous